Innovations in the Diagnosis of Cardiac Autonomic Neuropathy in Patients with Diabetes Mellitus Type 2
DOI:
https://doi.org/10.61788/njn.spec.17.22Keywords:
cardiac autonomic neuropathy, heart rate variability, hyperglycemia, type 2 diabetes mellitusAbstract
Diabetic neuropathy is a multifaceted problem and requires joint efforts of endocrinologists to early diagnose the recognition and treatment of this complication. Diabetic autonomic cardiac neuropathy is one of the manifestations of nerve fiber damage in diabetes mellitus. Cardiac neuropathy is one of the variants of heart failure in conditions of hyperglycemia. The proposed article discusses new methods for diagnosis cardiac autonomic neuropathy in patients with type 2 diabetes mellitus.
References
Никонова Ю.М., Феликсова О.М., Хромова А.В., Бебякова Н.А. Ассоциация генетического полиморфизма гена эндотелиальной синтазы оксида азота с сердечно-сосудистой патологией // Современные проблемы науки и образования, 2015.
Лукина Е.У., Петрухин И.С. Диагностическая ценность спектрального анализа вариабельности сердечного ритма сердца для выявления автономной диабетической нейропатии при сахарном диабете типа 2//Российский кардиологический журнал N3 (95)/2012; c.42-46.
Vinik A.I., Zigler D. Diabetic cardiovascular autonomic neuropathy // Circulation, 2007, vol. 115, p. 387-397.
Waqar F., Gerson M.C. Cardiac sympathetic imaging in the diagnosis of cardiac autonomic neuropathy in pre-diabetes // Journal of Nuclear Cardiology, 2015, vol.22, Issue 6, p. 1269-1272.
WHO. World Health Organization. About diabetes. Retrieved 4 April 2014.
Whiting D.R., Guariguata L., Weil C. et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030 // Diabetes Res Clin Pract., 2011, vol.94, p.311–321.
Wu D., Li L., Liu C. Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysys // Diabetes, Obes. and Metab., 2014, vol. 16, No1, p.30-37.
Yamada T., Yoshitama T., Makino K. et al. Heart rate recovery after exercise is a predictor of silent myocardial ischemia in patients with type 2 diabetes // Diabetes Care, 2011, vol. 34 (3), p. 724-726.
Ziegler D., Gries F.A., Muhlen H. et al. Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes center. The DiaCAN Multicenter Study Group // Diabetes Metab., 1993, No19, p. 143–151.
Максимова О.В., Субботина В.Г., Оленко Е.С. и др. Значение оценки интервала QT у больных сахарным диабетом 2 типа в сочетании с ИБС // Международный журнал прикладных и фундаментальных исследований, 2011, №3, с. 112-116.
Ziegler D., Zentai C.P., Perz S. et al. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study // Diabetes Care, 2008, Nо.31, p.556–561.
Zintzaras E., Papathanasiou A.A., Stefanidis I. Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: a HuGE review and meta-analysis // Genet. Med., 2009, vol. 11, No10, р. 695-706.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 National Association of Neurologists
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
